Literature DB >> 4370795

Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.

R M Krauss, R I Levy, D S Fredrickson.   

Abstract

An assay has been developed for specific measurement of two different lipase activities in postheparin plasma. Lipoprotein lipase, derived from extrahepatic sources, is measured as protamine-inactivated lipase activity; hepatic lipase activity is protamine-resistant under the conditions of this assay. In 100 normal subjects, both enzyme activities were noted to be related to age and sex. Protamine-resistant lipase, which comprised 46-95% of the total activity, was highest in men over 18. Protamine-inactivated lipase activity was greatest in younger males and was age-correlated in women, doubling between the second and sixth decades. In 12 patients with hyperchylomicronemia, including five previously shown to have familial type I hyperlipoproteinemia, protamine-inactivated lipase activity was markedly reduced, whereas protamine-resistant lipase was below normal in only 1. The results were not due to lack of plasma activator, presence of plasma inhibitor, or diet, and the deficiency was not overcome by increasing the provoking dose of heparin from 10 U to 75 U/kg. Mean values for both lipase activities were not reduced in 32 other patients with hyperchylomicronemia, nine with "floating beta" lipoproteins (type III hyperlipoproteinemia), and 23 with hyperprebetalipoproteinemia (type IV). Mean protamine-resistant lipase activity was below normal in a group of four women with hypothyroidism, in whom protamine-inactivated lipase was not reduced. Both of the lipase activities were capable of hydrolyzing lipid in very low-density lipoproteins, but the relative rate of hydrolysis of chylomicrons by protamine-resistant lipase was markedly limited. These results indicate the importance of distinguishing between lipases of hepatic and extra-hepatic origin in the measurement of postheparin lipolytic activity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4370795      PMCID: PMC301659          DOI: 10.1172/JCI107855

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil.

Authors:  E D KORN
Journal:  J Biol Chem       Date:  1955-07       Impact factor: 5.157

3.  SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD.

Authors:  P J Nestel; R J Havel; A Bezman
Journal:  J Clin Invest       Date:  1962-10       Impact factor: 14.808

4.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.

Authors:  J D Brunzell; W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

5.  Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver.

Authors:  G Assmann; R M Krauss; D S Fredrickson; R I Levy
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

6.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

Review 7.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

8.  Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives.

Authors:  W R Hazzard; M J Spiger; J D Bagdade; E L Bierman
Journal:  N Engl J Med       Date:  1969-02-27       Impact factor: 91.245

9.  Studies of the proteins in human plasma very low density lipoproteins.

Authors:  W V Brown; R I Levy; D S Fredrickson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

10.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons.

Authors:  T G Redgrave
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  42 in total

1.  Genomic interval engineering of mice identifies a novel modulator of triglyceride production.

Authors:  Y Zhu; M C Jong; K A Frazer; E Gong; R M Krauss; J F Cheng; D Boffelli; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism.

Authors:  M L Kashyap; L S Srivastava; B A Hynd; G Perisutti; D W Brady; P Gartside; C J Glueck
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

3.  Changes in plasma lipoprotein distribution and formation of two unusual particles after heparin-induced lipolysis in hypertriglyceridemic subjects.

Authors:  T M Forte; R M Krauss; F T Lindgren; A V Nichols
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

Review 4.  The lipoprotein lipase system: new understandings.

Authors:  M H Tan
Journal:  Can Med Assoc J       Date:  1978-03-18       Impact factor: 8.262

5.  Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity.

Authors:  Verónica Miksztowicz; Laura Schreier; Mary McCoy; Diego Lucero; Eduardo Fassio; Jeffrey Billheimer; Daniel J Rader; Gabriela Berg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

6.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Authors:  C S Wang; W J McConathy; H U Kloer; P Alaupovic
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  HDL composition regulates displacement of cell surface-bound hepatic lipase.

Authors:  Naghmeh Rouhani; Elizabeth Young; Cynthia Chatterjee; Daniel L Sparks
Journal:  Lipids       Date:  2008-08-01       Impact factor: 1.880

8.  Effects of exercise with varying energy expenditure on high-density lipoprotein-cholesterol.

Authors:  P S Visich; F L Goss; P M Gordon; R J Robertson; V Warty; B G Denys; K F Metz
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease.

Authors:  P W Connelly; G F Maguire; J A Little
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.